AbbVie (ABBV) Profit After Tax (2012 - 2026)

AbbVie (ABBV) has 15 years of Profit After Tax data on file, last reported at $697.0 million in Q1 2026.

• Profit After Tax for Q1 2026 came in at $697.0 million, down 45.93% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.6 billion (down 13.43% YoY), and the FY2025 annual result was $4.2 billion, down 1.4% from the prior year.
• Profit After Tax slipped to $697.0 million in Q1 2026 per ABBV's latest filing, from $1.8 billion in the prior quarter.
• Over five years, Profit After Tax peaked at $4.5 billion in Q1 2022 and troughed at -$22.0 million in Q4 2024.
• A 5-year average of $1.5 billion and a median of $1.4 billion in 2024 frame the typical range for Profit After Tax.
• The sharpest annual moves came in 2024 and 2025: Profit After Tax sank 102.68% in 2024, then soared 8354.55% in 2025.
• A 5-year view of Profit After Tax shows it stood at $2.5 billion in 2022, then plunged by 66.76% to $822.0 million in 2023, then tumbled by 102.68% to -$22.0 million in 2024, then soared by 8354.55% to $1.8 billion in 2025, then sank by 61.62% to $697.0 million in 2026.
• Business Quant data shows ABBV's Profit After Tax at $697.0 million in Q1 2026, $1.8 billion in Q4 2025, and $186.0 million in Q3 2025.